Özkan, S. and Gezer, D. (2025) “The impact of dapagliflozin on FIB-4 index over 2 years in patients with type 2 diabetes mellitus”, The European Research Journal, 11(4), pp. 676–682. doi:10.18621/eurj.1631079.